PRESS RELEASE published on 08/05/2025 at 09:55, 1 year 1 month ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 1 year 1 month ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
BRIEF published on 06/11/2025 at 08:55, 1 year 3 months ago SCHOTT Pharma prolonge le contrat de son PDG et nomme un nouveau directeur financier Expansion Mondiale Prolongation Du Contrat Du PDG Nomination D'un Nouveau Directeur Financier Confinement Pharmaceutique Leadership Innovant
BRIEF published on 06/11/2025 at 08:55, 1 year 3 months ago SCHOTT Pharma Extends CEO Contract and Appoints New CFO Global Expansion CEO Contract Extension Innovative Leadership New CFO Appointment Pharmaceutical Containment
PRESS RELEASE published on 06/11/2025 at 08:50, 1 year 3 months ago SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO SCHOTT Pharma extends CEO's contract Andreas Reisse & appoints Reinhard Mayer as CFO. Strategic personnel changes at SCHOTT Pharma AG & Co. KGaA CFO Appointment SCHOTT Pharma Personnel Changes CEO Contract Reinhard Mayer
BRIEF published on 06/04/2025 at 15:35, 1 year 3 months ago SCHOTT Pharma Expands Sterile Cartridge Production in Hungary Expansion Pharmaceutical SCHOTT Pharma Hungary Sterile Cartridges
BRIEF published on 06/04/2025 at 15:35, 1 year 3 months ago SCHOTT Pharma étend sa production de cartouches stériles en Hongrie Expansion SCHOTT Pharma Pharmaceutique Hongrie Cartouches Stériles
PRESS RELEASE published on 06/04/2025 at 15:30, 1 year 3 months ago SCHOTT Pharma invests in sterile cartridge production in Hungary SCHOTT Pharma invests over EUR 100 million in new sterile cartridge production facility in Hungary to meet market demand for high-value solutions Expansion Investment SCHOTT Pharma Hungary Sterile Cartridge Production
BRIEF published on 05/15/2025 at 07:05, 1 year 4 months ago SCHOTT Pharma annonce de solides performances au deuxième trimestre 2025 SCHOTT Pharma Croissance Des Revenus Des Solutions À Forte Valeur Ajoutée Résultats Du Deuxième Trimestre 2025 Innovations Pharmaceutiques
BRIEF published on 05/15/2025 at 07:05, 1 year 4 months ago SCHOTT Pharma Reports Strong Q2 2025 Performance Revenue Growth SCHOTT Pharma High-value Solutions Pharmaceutical Innovations Q2 2025 Results
Published on 10/03/2026 at 02:35, 21 hours 30 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 10 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 11 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 11 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 8 hours 20 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 3 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 4 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 1 day 5 hours ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 17:45, 1 day 6 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 6 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 6 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 6 hours ago Aéroports de Paris SA - Calendrier financier 2027
